2,689
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy

, , , , , , , , , , , , , , , , , , , & show all
Article: 2200868 | Received 20 Jan 2023, Accepted 30 Mar 2023, Published online: 16 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.